About Platform Solutions Case studies Inclusion debt Trust & ethics Press Blog Resources Toolkits Take the Scorecard Contact us
Solutions

Six fixed-price engagements. One dataset behind every one.

Regulatory affairs, medical affairs and market-access budgets are annual line items. That is why every Equity Engine engagement is fixed scope, fixed duration. No open-ended discovery. No burn-rate consulting.

Filter by buyer:
Pharma & biotech

JCA-Ready Evidence Package

The submission-ready patient-input and subgroup-evidence file the EU Joint Clinical Assessment framework requires, delivered inside the 100-day JCA window.

For: Pharma medical-affairs, market-access and HEOR leads with a JCA scheduled in the next 6 to 18 months.
JCANICEG-BA
Pharma & biotech

Patient Council as a Service

A standing Patient Council embedded in your medical-affairs function, on-demand for HTA questions, label reviews, protocol amendments and communications.

For: Pharma medical-affairs, patient-partnership and market-access teams who need a repeatable, auditable patient-input function.
JCANIHR INCLUDEMHRA IDP
Medtech & digital health

SaMD Population Performance Red-Team

An independent stress-test of your Software-as-a-Medical-Device algorithm against the populations your training data under-represents, the exact evidence MHRA and NICE now expect.

For: SaMD manufacturers and AI medical-device developers preparing for MHRA submission, or defending a live approval.
MHRA IDPNICE ESFNHS DTAC
Medtech & digital health

ESF/DTAC Evidence Pack

The digital-health evidence pack aligned to NICE ESF Standard 4 and NHS DTAC, including the subgroup evidence NHS procurement now asks about first.

For: Digital-health founders, product leads and NHS-facing commercial teams entering procurement in the next 6 to 12 months.
NICE ESFNHS DTAC
Medtech & digital health

PMCF Equity Gap Assessment

A structured, submission-ready Post-Market Clinical Follow-Up equity gap assessment against MHRA UK PMS 2025 and EU MDR Annex XIV.

For: Medical-device and SaMD manufacturers with a live PMS obligation.
UK PMS 2025MDR Annex XIV
Academic, NIHR & non-profit

NIHR PPI Package

A fully-costed Patient and Public Involvement partnership for NIHR-funded research, built on the NIHR INCLUDE framework, with community-partner MOUs already in place.

For: Academic Principal Investigators writing NIHR grants or running NIHR-funded studies that must satisfy INCLUDE.
NIHR INCLUDEResearch for Patient Benefit

Not ready for a fixed-price engagement?

The Unwritten Health Toolkits are three self-serve PDF resources for practitioners who want to start capturing patient experience data now. Not the same as the enterprise engagements above, but useful as a starting point.

Browse the toolkits →
Not sure which fits?

Take the Regulatory Readiness Scorecard.

Twenty questions, six domains, a plain-English diagnosis of the regulatory clauses you are exposed under, and the specific fixed-price engagement that closes each gap.

Take the Scorecard →